Juva Life Past Earnings Performance
Past criteria checks 0/6
Juva Life has been growing earnings at an average annual rate of 27.7%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 43% per year.
Key information
27.7%
Earnings growth rate
28.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 43.0% |
| Return on equity | -144.1% |
| Net Margin | -85.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Juva Life makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 8 | -7 | 5 | 1 |
| 30 Jun 23 | 6 | -9 | 5 | 1 |
| 31 Mar 23 | 6 | -9 | 6 | 1 |
| 31 Dec 22 | 6 | -10 | 8 | 0 |
| 30 Sep 22 | 6 | -9 | 9 | 0 |
| 30 Jun 22 | 5 | -8 | 9 | 0 |
| 31 Mar 22 | 4 | -9 | 9 | 0 |
| 31 Dec 21 | 4 | -11 | 10 | 0 |
| 30 Sep 21 | 3 | -18 | 12 | 0 |
| 30 Jun 21 | 2 | -20 | 13 | 0 |
| 31 Mar 21 | 2 | -20 | 13 | 0 |
| 31 Dec 20 | 1 | -16 | 11 | 0 |
| 30 Sep 20 | 1 | -14 | 10 | 0 |
| 30 Jun 20 | 0 | -12 | 8 | 0 |
| 31 Mar 20 | 0 | -10 | 7 | 0 |
| 31 Dec 19 | 0 | -9 | 6 | 0 |
Quality Earnings: JUVA.F is currently unprofitable.
Growing Profit Margin: JUVA.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if JUVA.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare JUVA.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: JUVA.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: JUVA.F has a negative Return on Equity (-144.14%), as it is currently unprofitable.